Tuesday, April 4, 2023

1:00 PM - 2:00 PM ET 
10:00 AM - 11:00 AM PT

Interactive, Live webinar
 

Target Audience

This CE activity is intended for hematologist/oncologists, oncology nurses, social workers, and other healthcare professionals involved in the care of patients with chronic lymphocytic leukemia.
 

    Educational Objectives

    After completing this CE activity, the participant should be better able to:

    • Describe the types and subtypes of chronic lymphocytic leukemia (CLL)

    • Identify tests used to diagnose disease and monitor treatment

    • Explain approved and emerging treatment options for CLL

    • Describe strategies to manage treatment side effects as well as long-term and late effects of treatments

    • Review vaccination strategies, the impact of COVID-19, and importance of screening for secondary cancers

    • Describe the role of the multidisciplinary healthcare team in managing patients with CLL

    Speakers

    William Wierda, MD, PhD 
    Professor of Medicine
    Section Head – CLL
    Department of Leukemia
    The University of Texas MD Anderson Cancer Center
    Houston, TX
     
    Jill Miller, MS, PA-C

    Manager, Advanced Practice Providers

    Department of Leukemia
    The University of Texas MD Anderson Cancer Center
    Houston, TX


    This activity is provided by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society

    There is no commercial support associated with this CE activity.

    For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.

    Follow LLS